Law firm Levi & Korsinsky has launched an investigation into Prestige Consumer Healthcare Inc. (NYSE: PBH) over potential violations of federal securities laws, the firm announced on May 18, 2026.
The inquiry stems from statements made during the company’s third-quarter fiscal 2026 earnings call, where CEO Ron Lombardi stated that Prestige Consumer Healthcare anticipated a 57 percent adjusted gross margin in the fourth quarter.
The investigation by the securities litigation firm will examine whether the company's forward-looking statements may have been materially misleading to the investing public. Such probes often precede the filing of a class-action lawsuit on behalf of shareholders who may have suffered losses.
The announcement introduces legal and financial risks for Prestige, potentially leading to increased volatility in its stock price. Investor uncertainty is likely to rise due to the perceived legal jeopardy and potential for reputational damage.
The investigation creates a new layer of uncertainty for shareholders, who will be watching for an official response from Prestige Consumer Healthcare or the potential filing of a formal complaint. The outcome of this probe could have significant financial implications for the company.
This article is for informational purposes only and does not constitute investment advice.
